<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2019-12-02">
  <drugbank-id primary="true">DB11209</drugbank-id>
  <name>Iron protein succinylate</name>
  <description/>
  <cas-number>250705-13-6</cas-number>
  <unii>VBJ9L90P4L</unii>
  <groups>
    <group>approved</group>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>PR Natal 400</name>
      <labeller>PruGen, Inc Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>42546-811</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PR Natal 400 ec</name>
      <labeller>PruGen, Inc Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>42546-517</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PR Natal 430</name>
      <labeller>PruGen, Inc Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>42546-812</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PR Natal 430 ec</name>
      <labeller>PruGen, Inc Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>42546-518</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Remedient</name>
      <labeller>Levins Pharmaceuticals, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>71905-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Triveen-Duo DHA</name>
      <labeller>Trigen Laboratories, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>13811-591</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>PR Natal 430</name>
      <ingredients>Ascorbic acid + Beta carotene + Calcium carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + DL-alpha tocopheryl acetate + Ferrous bisglycinate + Folic acid + Iron protein succinylate + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PR Natal 400</name>
      <ingredients>Ascorbic acid + Beta carotene + Calcium carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + DL-alpha tocopheryl acetate + Ferrous bisglycinate + Folic acid + Iron protein succinylate + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PR Natal 430 ec</name>
      <ingredients>Ascorbic acid + Beta carotene + Calcium carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + DL-alpha tocopheryl acetate + Ferrous bisglycinate + Folic acid + Iron protein succinylate + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PR Natal 400 ec</name>
      <ingredients>Ascorbic acid + Beta carotene + Calcium carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + DL-alpha tocopheryl acetate + Ferrous bisglycinate + Folic acid + Iron protein succinylate + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Remedient</name>
      <ingredients>Ascorbic acid + Calcium Citrate + Carnosine + Cyanocobalamin + Folic acid + Iron protein succinylate + Magnesium glycinate + Magnesium oxide + Polaprezinc + Vitamin D + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Triveen-Duo DHA</name>
      <ingredients>Ascorbic acid + Beta carotene + Calcium carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + DL-alpha tocopheryl acetate + Doconexent + Ferrous bisglycinate + Folic acid + Iron protein succinylate + Magnesium oxide + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Zinc oxide</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids, Acyclic</category>
      <mesh-id>D000144</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Anemia, Hypochromic, drug therapy</category>
      <mesh-id/>
    </category>
    <category>
      <category>Dicarboxylic Acids</category>
      <mesh-id>D003998</mesh-id>
    </category>
    <category>
      <category>Ferric Compounds</category>
      <mesh-id>D005290</mesh-id>
    </category>
    <category>
      <category>Hematinics</category>
      <mesh-id>D006397</mesh-id>
    </category>
    <category>
      <category>Hematologic Agents</category>
      <mesh-id>D006401</mesh-id>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Kit</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form/>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>